In a recent wide-scale clinical study studying both HCC and cirrhotic patients, Pestana and co-workers showed that high Ang-1 levels are associated with an increase in the overall survival of patients diagnosed with HCC, showing that plasma Ang-1 is a potential diagnostic and prognostic biomarker in HCC [40]. This evidence concerns the gene ANGPT1 and hepatocellular carcinoma.